Croda

Abstract Background/Objectives: The stability and biological safety of newly developed formulations must be established to support their therapeutic efficacy and...

Abstract Poor aqueous solubility limits the in vitro dissolution performance of many drugs, among them curcumin which is a bioactive...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

Peptide therapeutics are critical therapeutics for a range of pathologies. Their recent uptake as a treatment for obesity has seen...

Peptide injectable development can bring complex formulation challenges, especially in diabetes and obesity where GLP-1 therapeutics need to maintain stability,...

Abstract In the pediatric patient group, there is a constant need for individualized dosage forms with precise and adjustable drug...

Abstract Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic...

Abstract Background: The therapeutic potential of many natural products, including curcumin (CUR), betulinic acid (BA), and oleanolic acid (OA), is limited...

Ingredient security is no longer a background consideration for vaccine formulators and manufacturers. It is now critical high-quality ingredients are...

Abstract Dapivirine (DPV) is an antiretroviral drug used for prevention of sexually acquired HIV infection in the form of a...